|
Baseline characteristic
|
HCAP
|
HAP
|
VAP
|
p value
|
|---|
| |
(n = 199)
|
(n = 379)
|
(n = 606)
| |
|---|
|
Age, y, mean (SD)
|
69.5 (13.4)
|
63.3 (15.8)
|
55.8 (19.8)
|
< 0.001
|
|
Male, n (%)
|
117 (58.8)
|
247 (65.2)
|
411 (67.8)
|
0.067
|
|
APACHE II, mean (SD)
|
18.7 (6.4)
|
16.1 (6.3)
|
17.8 (5.7)
|
< 0.001
|
|
Race, n (%)
| | | |
< 0.001
|
|
White
|
151 (75.9)
|
217 (57.3)
|
429 (70.8)
| |
|
Black
|
25 (12.6)
|
28 (7.4)
|
72 (11.9)
| |
|
Asian
|
18 (9.1)
|
97 (25.6)
|
56 (9.2)
| |
|
Other
|
5 (2.5)
|
37 (9.8)
|
49 (8.1)
| |
|
Region, n (%)
| | | |
< 0.001
|
|
United States
|
174 (87.4)
|
163 (43.0)
|
376 (62.1)
| |
|
Europe
|
6 (3.0)
|
51 (13.5)
|
84 (13.9)
| |
|
Latin America
|
2 (1.0)
|
43 (11.4)
|
78 (12.9)
| |
|
Asia
|
14 (7.0)
|
93 (24.5)
|
49 (8.1)
| |
|
Other
|
3 (1.5)
|
29 (7.7)
|
19 (3.1)
| |
|
Comorbidities, n (%)
| | | | |
|
Cardiac
|
153 (76.9)
|
198 (52.2)
|
359 (59.2)
|
< 0.001
|
|
Pulmonary
|
164 (82.4)
|
186 (49.1)
|
387 (63.9)
|
< 0.001
|
|
Renal/Urinary
|
110 (55.3)
|
127 (33.5)
|
194 (32.0)
|
< 0.001
|
|
Diabetes
|
98 (49.3)
|
128 (33.8)
|
198 (32.7)
|
< 0.001
|
|
Vascular
|
74 (37.2)
|
109 (28.8)
|
187 (30.9)
|
0.111
|
|
Neoplastic
|
23 (11.6)
|
68 (17.9)
|
42 (6.9)
|
< 0.001
|
|
Hepatobiliary
|
17 (8.5)
|
42 (11.1)
|
91 (15.0)
|
0.031
|
-
APACHE, Acute Physiology and Chronic Health Evaluation; HAP, Hospital-acquired pneumonia; HCAP, Healthcare-associated pneumonia; VAP, Ventilator-associated pneumonia.
